Tag: GLP-1 Receptor Agonist

Reduced Mortality: Why GLP-1s and the “Dream Team” of Podiatry, Diabetes Care, and Opthalmology Are Changing the DFU Game @DiabetesCareADA #ActAgainstAmputation #Survival

We’ve known for a long time that a diabetic foot ulcer (DFU) isn’t just a wound on the bottom of a foot—it’s a massive red flare for a patient’s overall health. But a recent nationwide study in Diabetes Care just put some sobering, and ultimately hopeful, numbers behind that reality. The data from this massive... Continue Reading →

0

Beyond Glycemic Control: Exploring GLP-1 Agonists for Diabetic Foot Ulcer Healing

Introduction The battle against diabetic foot ulcers (DFUs) remains one of the most challenging aspects of diabetes care. With recent advances in diabetes medications, specifically GLP-1 receptor agonists (GLP-1 RAs), there is growing interest in how these drugs might support wound healing and improve DFU outcomes. Traditionally prescribed for glycemic control, GLP-1 RAs are showing... Continue Reading →

0

Up ↑

Verified by MonsterInsights